Atorvastatin Prevents Angiotensin II–Induced Vascular Remodeling and Oxidative Stress

Microvessel vascular smooth muscle cells contribute to collagen type I deposition through ERK1/2 MAP kinase, αvβ3-integrin, and TGF-β1 in response to ANG II and high glucose

(2008) Souad Belmadani et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Redox Signaling, Vascular Function, and Hypertension

(2008) Moo Yeol Lee et al.   ANTIOXIDANTS & REDOX SIGNALING

Reduction in Blood Pressure With StatinsResults From the UCSD Statin Study, a Randomized Trial

(2008) Beatrice A. Golomb   ARCHIVES OF INTERNAL MEDICINE

Impaired Tissue Perfusion

(2008) Bernard I. Levy et al.   CIRCULATION

Fluvastatin decreases cardiac fibrosis possibly through regulation of TGF-β1/Smad 7 expression in the spontaneously hypertensive rats

(2008) Yuansheng Zhai et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Anti-hypertensive effects of Rosuvastatin are associated with decreased inflammation and oxidative stress markers in hypertensive rats

(2008) Pierre Sicard et al.   FREE RADICAL RESEARCH

Small artery remodelling in hypertension: causes, consequences and therapeutic implications

(2008) Michael J. Mulvany   MEDICAL & BIOLOGICAL ENGINEERING & COMPUTING

Pleiotropic effects of statin therapy: molecular mechanisms and clinical results

(2008) Chao-Yung Wang et al.   TRENDS IN MOLECULAR MEDICINE

Pitavastatin, an HMG-CoA Reductase Inhibitor, Exerts eNOS-Independent Protective Actions Against Angiotensin II–Induced Cardiovascular Remodeling and Renal Insufficiency

(2007) Shusuke Yagi et al.   CIRCULATION RESEARCH